139 related articles for article (PubMed ID: 9844683)
1. T1 effects of a bolus-injectable superparamagnetic iron oxide, SH U 555 A: dependence on field strength and plasma concentration--preliminary clinical experience with dynamic T1-weighted MR imaging.
Reimer P; Müller M; Marx C; Wiedermann D; Muller R; Rummeny EJ; Ebert W; Shamsi K; Peters PE
Radiology; 1998 Dec; 209(3):831-6. PubMed ID: 9844683
[TBL] [Abstract][Full Text] [Related]
2. [Dynamic MR imaging of liver lesions with superparamagnetic iron oxide (SH-U-555A)].
Saito K; Ishida J; Ito N; Kakizaki D; Kotake F; Abe K
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Feb; 61(3):84-8. PubMed ID: 11265126
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
Vogl TJ; Schwarz W; Hammerstingl R; Kümmel S; Balzer JO; Mack MG; Diebold T; Balzer T; Shamsi K; Bechstein WO; Schrem H; Neuhaus P; Felix R
Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
[TBL] [Abstract][Full Text] [Related]
4. [T1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist): results of a phantom study as well as 25 patients].
Müller M; Reimer P; Wiedermann D; Allkemper T; Marx C; Tombach B; Rummeny EJ; Shamsi K; Balzer T; Peters PE
Rofo; 1998 Mar; 168(3):228-36. PubMed ID: 9551108
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
[TBL] [Abstract][Full Text] [Related]
6. [MRI of arthritis with the USPIO SH U 555 C: optimization of T1 enhancement].
Simon G; Daldrup-Link H; von Vopelius-Feldt J; Wendland M; Fu Y; Schlegel J; Rummeny E
Rofo; 2006 Feb; 178(2):200-6. PubMed ID: 16435251
[TBL] [Abstract][Full Text] [Related]
7. Hepatic MRI with SPIO: detection and characterization of focal liver lesions.
Reimer P; Tombach B
Eur Radiol; 1998; 8(7):1198-204. PubMed ID: 9724439
[TBL] [Abstract][Full Text] [Related]
8. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
[TBL] [Abstract][Full Text] [Related]
9. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions.
Mergo PJ; Helmberger T; Nicolas AI; Ros PR
AJR Am J Roentgenol; 1996 Feb; 166(2):379-84. PubMed ID: 8553952
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).
Reimer P; Allkemper T; Matuszewski L; Balzer T
J Magn Reson Imaging; 1999 Jul; 10(1):65-71. PubMed ID: 10398979
[TBL] [Abstract][Full Text] [Related]
11. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
12. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis.
Ward J; Naik KS; Guthrie JA; Wilson D; Robinson PJ
Radiology; 1999 Feb; 210(2):459-66. PubMed ID: 10207430
[TBL] [Abstract][Full Text] [Related]
13. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
[TBL] [Abstract][Full Text] [Related]
14. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
16. Clinical results with Resovist: a phase 2 clinical trial.
Reimer P; Rummeny EJ; Daldrup HE; Balzer T; Tombach B; Berns T; Peters PE
Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
Chambon C; Clement O; Le Blanche A; Schouman-Claeys E; Frija G
Magn Reson Imaging; 1993; 11(4):509-19. PubMed ID: 8316064
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.
Shamsi K; Balzer T; Saini S; Ros PR; Nelson RC; Carter EC; Tollerfield S; Niendorf HP
Radiology; 1998 Feb; 206(2):365-71. PubMed ID: 9457187
[TBL] [Abstract][Full Text] [Related]
19. [New MR contrast media in liver diagnosis. Initial clinical results with hepatobiliary Eovist (gadolinium-EOB-DTPA) and RES-specific Resovist (SH U 555 A)].
Reimer P; Tombach B; Daldrup H; Hesse T; Sander G; Balzer T; Shamsi K; Berns T; Rummeny EJ; Peters PE
Radiologe; 1996 Feb; 36(2):124-33. PubMed ID: 8867429
[TBL] [Abstract][Full Text] [Related]
20. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
Winter TC; Freeny PC; Nghiem HV; Mack LA; Patten RM; Thomas CR; Elliott S
AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
